‘Alzheimer’s’ directory
- See Also
-
Links
- “An Analysis on the Role of Glucagon-Like Peptide-1 Receptor Agonists in Cognitive and Mental Health Disorders”, Giorgi et al 2025
- “Mapping the Effectiveness and Risks of GLP-1 Receptor Agonists”, Xie et al 2025
- “Lifetime Risk and Projected Burden of Dementia”, Fang et al 2025
- “Age against the Machine—Susceptibility of Large Language Models to Cognitive Impairment: Cross Sectional Analysis”
- “Political Fundraisers WinRed and ActBlue Are Taking Millions of Dollars in Donations from Elderly Dementia Patients to Fuel Their Campaigns”
- “Why Do Obesity Drugs Seem to Treat so Many Other Ailments?”
- “The Rise of the Science Sleuths”
- “Nasal Tau Immunotherapy Clears Intracellular Tau Pathology and Improves Cognitive Functions in Aged Tauopathy Mice”, Gaikwad et al 2024
- “Differences in Early Life Cognitive Function Explain the Association between Low Education and Early Dementia Risk”, Bratsberg et al 2024
- “Trial of Lixisenatide in Early Parkinson’s Disease”, Meissner et al 2024
- “Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer’s Disease”, Rezai et al 2024
- “Lee Holloway: The Devastating Decline of a Brilliant Young Coder”
- “Senolytic Therapy in Mild Alzheimer’s Disease: a Phase 1 Feasibility Trial”, Gonzales et al 2023
- “The Vanishing Family: They All Have a 50-50 Chance of Inheriting a Cruel Genetic Mutation—Which Means Disappearing into Dementia in Middle Age. This Is the Story of What It’s like to Live With Those Odds”, Kolker 2023
- “Multi-Ancestry Genome-Wide Meta-Analysis of 56,241 Individuals Identifies LRRC4C, LHX5-AS1 and Nominates Ancestry-Specific Loci PTPRK, GRB14, and KIAA0825 As Novel Risk Loci for Alzheimer Disease: the Alzheimer Disease Genetics Consortium”, Rajabli et al 2023
- “I Lost 40 Pounds on Ozempic. But I’m Left With Even More Questions.”, Marcus 2023
- “Causal Evidence That Herpes Zoster Vaccination Prevents a Proportion of Dementia Cases”, Eyting et al 2023
- “Soluble Pathogenic Tau Enters Brain Vascular Endothelial Cells and Drives Cellular Senescence and Brain Microvascular Dysfunction in a Mouse Model of Tauopathy”, Hussong et al 2023
- “Association between Hearing Aid Use and All-Cause and Cause-Specific Dementia: an Analysis of the UK Biobank Cohort”, Jiang et al 2023
- “Virus Exposure and Neurodegenerative Disease Risk across National Biobanks”, Levine et al 2023
- “The APOE Locus Is Linked to Decline in General Cognitive Function: 20-Years Follow-Up in the Doetinchem Cohort Study”, Rietman et al 2022
- “Data Descriptor: Human Whole Exome Genotype Data for Alzheimer’s Disease”, Leung et al 2022
- “Association of Whole-Person Eigen-Polygenic Risk Scores With Alzheimer’s Disease”, Kharaghani et al 2022
- “Lithium in Drinking Water and Alzheimer’s Dementia: Epidemiological Findings from National Data Base of Japan”, Muronaga et al 2022
- “What Does Heritability of Alzheimer’s Disease Represent?”, Baker et al 2022
- “Cognitive Functioning of Unaffected First-Degree Relatives of Individuals With Late-Onset Alzheimer’s Disease: A Systematic Literature Review and Meta-Analysis”, Ramos et al 2022
- “Evaluation of Transfer Learning Methods for Detecting Alzheimer’s Disease With Brain MRI”, Dhinagar et al 2022
- “White Matter Hyperintensities in Former American Football Players”, Alosco et al 2022
- “Genetic Architecture of the White Matter Connectome of the Human Brain”, Sha et al 2022
- “Polygenic Risk Score As a Possible Tool for Identifying Familial Monogenic Causes of Complex Diseases”, Lu et al 2022
- “Reduced Dementia Incidence After Varicella Zoster Vaccination in Wales 2013–2020”, Schnier et al 2022
- “New Insights into the Genetic Etiology of Alzheimer’s Disease and Related Dementias”, Bellenguez et al 2022
- “Genome-Wide Association Study of Occupational Attainment As a Proxy for Cognitive Reserve”, Ko et al 2022
- “Integrating Whole-Genome Sequencing With Multi-Omic Data Reveals the Impact of Structural Variants on Gene Regulation in the Human Brain”, Vialle et al 2022
- “Treatment With Glucagon-Like Peptide-1 Receptor Agonists and Incidence of Dementia: Data from Pooled Double-Blind Randomized Controlled Trials and Nationwide Disease and Prescription Registers”, Nørgaard et al 2022
- “Multi-Ancestry EQTL Meta-Analysis of Human Brain Identifies Candidate Causal Variants for Brain-Related Traits”, Zeng et al 2022
- “Identifying Imaging Genetic Associations via Regional Morphometricity Estimation”, Bao et al 2022
- “Evolution of Human-Specific Alleles Protecting Cognitive Function of Grandmothers”, Saha et al 2021
- “Genome-Wide Association Study of Cerebellar Volume”, Tissink et al 2021
- “Rare Variant Aggregation in 148,508 Exomes Identifies Genes Associated With Proxy Alzheimer’s Disease”, Wightman et al 2021
- “The Potential Role of Glial Cells in Driving the Prion-Like Transcellular Propagation of Tau in Tauopathies”, Amro et al 2021
- “The Viral Hypothesis: How Herpesviruses May Contribute to Alzheimer’s Disease”, Wainberg et al 2021
- “An Expanded Set of Genome-Wide Association Studies of Brain Imaging Phenotypes in UK Biobank”, Smith et al 2021c
- “Microglia Use TAM Receptors to Detect and Engulf Amyloid Β Plaques”, Huang et al 2021
- “Rare Genetic Variation Underlying Human Diseases and Traits: Results from 200,000 Individuals in the UK Biobank”, Jurgens et al 2020
- “Largest GWAS (n = 1,126,563) of Alzheimer’s Disease Implicates Microglia and Immune Cells”, Wightman et al 2020
- “Glymphatic Failure As a Final Common Pathway to Dementia”, Nedergaard & Goldman 2020
- “Amyloid, Tau and Risk of Alzheimer’s Disease: a Mendelian Randomization Study”, Yeung et al 2020
- “Discovery of 318 New Risk Loci for Type 2 Diabetes and Related Vascular Outcomes among 1.4 Million Participants in a Multi-Ancestry Meta-Analysis”, Vujkovic et al 2020
- “Disentangling Selection on Genetically Correlated Polygenic Traits Using Whole-Genome Genealogies”, Stern et al 2020
- “Computing Univariate Neurodegenerative Biomarkers With Volumetric Optimal Transportation: A Pilot Study”, Tu et al 2020
- “The Multiplex Model of the Genetics of Alzheimer’s Disease”, Sims et al 2020
- “Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Low Dose Lysergic Acid Diethylamide (LSD) in Healthy Older Volunteers”, Family et al 2020
- “Objective Subtle Cognitive Difficulties Predict Future Amyloid Accumulation and Neurodegeneration”, Thomas et al 2019
- “FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes”, FDA 2019
- “The Maddening Saga of How an Alzheimer’s ‘Cabal’ Thwarted Progress toward a Cure for Decades”, Begley 2019
- “Towards Clinical Utility of Polygenic Risk Scores”, Lambert et al 2019
- “The Advantages of Bilingualism Debate”, Antoniou 2019
- “Anti-Herpetic Medications and Reduced Risk of Dementia in Patients With Herpes Simplex Virus Infections-A Nationwide, Population-Based Cohort Study in Taiwan”, Tzeng et al 2018
- “Genome-Wide Association Meta-Analysis in 269,867 Individuals Identifies New Genetic and Functional Links to Intelligence”, Savage et al 2018
- “Incorporation of Tetanus-Epitope into Virus-Like Particles Achieves Vaccine Responses Even in Older Recipients in Models of Psoriasis, Alzheimer’s and Cat Allergy”, Zeltins et al 2017
- “Polygenic Risk Scores Applied to a Single Cohort Reveal Pleiotropy among Hundreds of Human Phenotypes”, Socrates et al 2017
- “Identifying Genetic Variants That Affect Viability in Large Cohorts”, Mostafavi et al 2017
- “Morphometricity As a Measure of the Neuroanatomical Signature of a Trait”, Sabuncu et al 2016
- “Genome-Wide Association Study of Cognitive Functions and Educational Attainment in UK Biobank (n = 112 151)”, Davies et al 2016
- “Shared Genetic Aetiology between Cognitive Functions and Physical and Mental Health in UK Biobank (n = 112,151) and 24 GWAS Consortia”, Hagenaars et al 2016
- “Genetic Contributions to Variation in General Cognitive Function: a Meta-Analysis of Genome-Wide Association Studies in the CHARGE Consortium (N = 53,949)”, Davies et al 2015
- “Common Polygenic Variation Enhances Risk Prediction for Alzheimer’s Disease”, Escott-Price et al 2015
- “Standard and Trace-Dose Lithium: A Systematic Review of Dementia Prevention and Other Behavioral Benefits”, Mauer et al 2014
- “Evaluation of Excess Statistical-Significance Bias in Animal Studies of Neurological Diseases”, Tsilidis et al 2013
- “Terminal Dedifferentiation of Cognitive Abilities”, Wilson et al 2012
- “Drugs Developed to Treat Diabetes, Liraglutide and Lixisenatide, Cross the Blood Brain Barrier and Enhance Neurogenesis”, Hunter & Hölscher 2012
- “Most Reported Genetic Associations With General Intelligence Are Probably False Positives”, Chabris et al 2012
- “How Citation Distortions Create Unfounded Authority: Analysis of a Citation Network”, Greenberg 2009
- “Lithium Trial in Alzheimer’s Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study”
- “Lithium May Be Useful in the Prevention of Alzheimer’s Disease in Individuals at Risk of Presenile Familial Alzheimer’s Disease”, Yeh & Tsai 2008
- “Temporal Cortex Direct Current Stimulation Enhances Performance on a Visual Recognition Memory Task in Alzheimer Disease”
- “A Feasibility and Tolerability Study of Lithium in Alzheimer’s Disease”
- “Prevalence of Cognitive Impairment without Dementia in the United States”, Plassman et al 2008
- “Smoking As a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies”, Anstey et al 2007
- “Lithium and Risk for Alzheimer’s Disease in Elderly Patients With Bipolar Disorder”, Nunes 2007
- “Global Prevalence of Dementia: a Delphi Consensus Study”, Ferri et al 2005
- “Bayesian Value-Of-Information Analysis: an Application to a Policy Model of Alzheimer’s Disease”, Caxton 2001
- “Worldwide Prevalence and Incidence of Dementia”, Fratiglioni et al 1999
- “Aging, Alzheimer’s Disease and Protein Crosslinking”, Klonowska & Klonowski 1986
- “Aging, Crosslinking and Alzheimer’s Disease”, Bjorksten et al 1984
- “Aluminum As a Cause of Senile Dementia”, Bjorksten 1982b
- “Dietary Aluminum and Alzheimer’s Disease”, Bjorksten 1982
- “Associations of Semaglutide With First-Time Diagnosis of Alzheimer’s Disease in Patients With Type 2 Diabetes: Target Trial Emulation Using Nationwide Real-World Data in the US”
- “The Alzheimer Photo”
- “Lithium’s Potential Role in Preventing Alzheimer’s Disease”
- “Digital Biomarkers for Alzheimer’s Disease: the Mobile/wearable Devices Opportunity”
- “The Woman Who Could Smell Parkinson’s”
- “The Academic Culture of Fraud”
- “12-Month Neurological and Psychiatric Outcomes of Semaglutide Use for Type 2 Diabetes: a Propensity-Score Matched Cohort Study”
- “Why Do Humans Still Have a Gene That Increases the Risk of Alzheimer’s?”
- Wikipedia
- Miscellaneous
- Bibliography
See Also
Links
“An Analysis on the Role of Glucagon-Like Peptide-1 Receptor Agonists in Cognitive and Mental Health Disorders”, Giorgi et al 2025
“Mapping the Effectiveness and Risks of GLP-1 Receptor Agonists”, Xie et al 2025
Mapping the effectiveness and risks of GLP-1 receptor agonists
“Lifetime Risk and Projected Burden of Dementia”, Fang et al 2025
“Age against the Machine—Susceptibility of Large Language Models to Cognitive Impairment: Cross Sectional Analysis”
“Political Fundraisers WinRed and ActBlue Are Taking Millions of Dollars in Donations from Elderly Dementia Patients to Fuel Their Campaigns”
“Why Do Obesity Drugs Seem to Treat so Many Other Ailments?”
“The Rise of the Science Sleuths”
“Nasal Tau Immunotherapy Clears Intracellular Tau Pathology and Improves Cognitive Functions in Aged Tauopathy Mice”, Gaikwad et al 2024
“Differences in Early Life Cognitive Function Explain the Association between Low Education and Early Dementia Risk”, Bratsberg et al 2024
“Trial of Lixisenatide in Early Parkinson’s Disease”, Meissner et al 2024
“Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer’s Disease”, Rezai et al 2024
Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer’s Disease
“Lee Holloway: The Devastating Decline of a Brilliant Young Coder”
Lee Holloway: The Devastating Decline of a Brilliant Young Coder :
“Senolytic Therapy in Mild Alzheimer’s Disease: a Phase 1 Feasibility Trial”, Gonzales et al 2023
Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial
“The Vanishing Family: They All Have a 50-50 Chance of Inheriting a Cruel Genetic Mutation—Which Means Disappearing into Dementia in Middle Age. This Is the Story of What It’s like to Live With Those Odds”, Kolker 2023
“Multi-Ancestry Genome-Wide Meta-Analysis of 56,241 Individuals Identifies LRRC4C, LHX5-AS1 and Nominates Ancestry-Specific Loci PTPRK, GRB14, and KIAA0825 As Novel Risk Loci for Alzheimer Disease: the Alzheimer Disease Genetics Consortium”, Rajabli et al 2023
“I Lost 40 Pounds on Ozempic. But I’m Left With Even More Questions.”, Marcus 2023
I lost 40 pounds on Ozempic. But I’m left with even more questions.
“Causal Evidence That Herpes Zoster Vaccination Prevents a Proportion of Dementia Cases”, Eyting et al 2023
Causal evidence that herpes zoster vaccination prevents a proportion of dementia cases
“Soluble Pathogenic Tau Enters Brain Vascular Endothelial Cells and Drives Cellular Senescence and Brain Microvascular Dysfunction in a Mouse Model of Tauopathy”, Hussong et al 2023
“Association between Hearing Aid Use and All-Cause and Cause-Specific Dementia: an Analysis of the UK Biobank Cohort”, Jiang et al 2023
“Virus Exposure and Neurodegenerative Disease Risk across National Biobanks”, Levine et al 2023
Virus exposure and neurodegenerative disease risk across national biobanks
“The APOE Locus Is Linked to Decline in General Cognitive Function: 20-Years Follow-Up in the Doetinchem Cohort Study”, Rietman et al 2022
“Data Descriptor: Human Whole Exome Genotype Data for Alzheimer’s Disease”, Leung et al 2022
Data Descriptor: Human whole exome genotype data for Alzheimer’s Disease
“Association of Whole-Person Eigen-Polygenic Risk Scores With Alzheimer’s Disease”, Kharaghani et al 2022
Association of Whole-Person Eigen-Polygenic Risk Scores with Alzheimer’s Disease
“Lithium in Drinking Water and Alzheimer’s Dementia: Epidemiological Findings from National Data Base of Japan”, Muronaga et al 2022
“What Does Heritability of Alzheimer’s Disease Represent?”, Baker et al 2022
“Cognitive Functioning of Unaffected First-Degree Relatives of Individuals With Late-Onset Alzheimer’s Disease: A Systematic Literature Review and Meta-Analysis”, Ramos et al 2022
“Evaluation of Transfer Learning Methods for Detecting Alzheimer’s Disease With Brain MRI”, Dhinagar et al 2022
Evaluation of Transfer Learning Methods for Detecting Alzheimer’s Disease with Brain MRI
“White Matter Hyperintensities in Former American Football Players”, Alosco et al 2022
White matter hyperintensities in former American football players
“Genetic Architecture of the White Matter Connectome of the Human Brain”, Sha et al 2022
Genetic architecture of the white matter connectome of the human brain
“Polygenic Risk Score As a Possible Tool for Identifying Familial Monogenic Causes of Complex Diseases”, Lu et al 2022
“Reduced Dementia Incidence After Varicella Zoster Vaccination in Wales 2013–2020”, Schnier et al 2022
Reduced dementia incidence after varicella zoster vaccination in Wales 2013–2020
“New Insights into the Genetic Etiology of Alzheimer’s Disease and Related Dementias”, Bellenguez et al 2022
New insights into the genetic etiology of Alzheimer’s disease and related dementias
“Genome-Wide Association Study of Occupational Attainment As a Proxy for Cognitive Reserve”, Ko et al 2022
Genome-wide association study of occupational attainment as a proxy for cognitive reserve
“Integrating Whole-Genome Sequencing With Multi-Omic Data Reveals the Impact of Structural Variants on Gene Regulation in the Human Brain”, Vialle et al 2022
“Treatment With Glucagon-Like Peptide-1 Receptor Agonists and Incidence of Dementia: Data from Pooled Double-Blind Randomized Controlled Trials and Nationwide Disease and Prescription Registers”, Nørgaard et al 2022
“Multi-Ancestry EQTL Meta-Analysis of Human Brain Identifies Candidate Causal Variants for Brain-Related Traits”, Zeng et al 2022
“Identifying Imaging Genetic Associations via Regional Morphometricity Estimation”, Bao et al 2022
Identifying imaging genetic associations via regional morphometricity estimation
“Evolution of Human-Specific Alleles Protecting Cognitive Function of Grandmothers”, Saha et al 2021
Evolution of Human-specific Alleles Protecting Cognitive Function of Grandmothers
“Genome-Wide Association Study of Cerebellar Volume”, Tissink et al 2021
“Rare Variant Aggregation in 148,508 Exomes Identifies Genes Associated With Proxy Alzheimer’s Disease”, Wightman et al 2021
“The Potential Role of Glial Cells in Driving the Prion-Like Transcellular Propagation of Tau in Tauopathies”, Amro et al 2021
“The Viral Hypothesis: How Herpesviruses May Contribute to Alzheimer’s Disease”, Wainberg et al 2021
The viral hypothesis: how herpesviruses may contribute to Alzheimer’s disease
“An Expanded Set of Genome-Wide Association Studies of Brain Imaging Phenotypes in UK Biobank”, Smith et al 2021c
An expanded set of genome-wide association studies of brain imaging phenotypes in UK Biobank
“Microglia Use TAM Receptors to Detect and Engulf Amyloid Β Plaques”, Huang et al 2021
Microglia use TAM receptors to detect and engulf amyloid β plaques
“Rare Genetic Variation Underlying Human Diseases and Traits: Results from 200,000 Individuals in the UK Biobank”, Jurgens et al 2020
“Largest GWAS (n = 1,126,563) of Alzheimer’s Disease Implicates Microglia and Immune Cells”, Wightman et al 2020
Largest GWAS (n = 1,126,563) of Alzheimer’s Disease Implicates Microglia and Immune Cells
“Glymphatic Failure As a Final Common Pathway to Dementia”, Nedergaard & Goldman 2020
“Amyloid, Tau and Risk of Alzheimer’s Disease: a Mendelian Randomization Study”, Yeung et al 2020
Amyloid, tau and risk of Alzheimer’s disease: a Mendelian Randomization study
“Discovery of 318 New Risk Loci for Type 2 Diabetes and Related Vascular Outcomes among 1.4 Million Participants in a Multi-Ancestry Meta-Analysis”, Vujkovic et al 2020
“Disentangling Selection on Genetically Correlated Polygenic Traits Using Whole-Genome Genealogies”, Stern et al 2020
Disentangling selection on genetically correlated polygenic traits using whole-genome genealogies
“Computing Univariate Neurodegenerative Biomarkers With Volumetric Optimal Transportation: A Pilot Study”, Tu et al 2020
“The Multiplex Model of the Genetics of Alzheimer’s Disease”, Sims et al 2020
The multiplex model of the genetics of Alzheimer’s disease :
View PDF:
“Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Low Dose Lysergic Acid Diethylamide (LSD) in Healthy Older Volunteers”, Family et al 2020
“Objective Subtle Cognitive Difficulties Predict Future Amyloid Accumulation and Neurodegeneration”, Thomas et al 2019
Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration
“FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes”, FDA 2019
“The Maddening Saga of How an Alzheimer’s ‘Cabal’ Thwarted Progress toward a Cure for Decades”, Begley 2019
The maddening saga of how an Alzheimer’s ‘cabal’ thwarted progress toward a cure for decades
“Towards Clinical Utility of Polygenic Risk Scores”, Lambert et al 2019
“The Advantages of Bilingualism Debate”, Antoniou 2019
“Anti-Herpetic Medications and Reduced Risk of Dementia in Patients With Herpes Simplex Virus Infections-A Nationwide, Population-Based Cohort Study in Taiwan”, Tzeng et al 2018
“Genome-Wide Association Meta-Analysis in 269,867 Individuals Identifies New Genetic and Functional Links to Intelligence”, Savage et al 2018
“Incorporation of Tetanus-Epitope into Virus-Like Particles Achieves Vaccine Responses Even in Older Recipients in Models of Psoriasis, Alzheimer’s and Cat Allergy”, Zeltins et al 2017
“Polygenic Risk Scores Applied to a Single Cohort Reveal Pleiotropy among Hundreds of Human Phenotypes”, Socrates et al 2017
“Identifying Genetic Variants That Affect Viability in Large Cohorts”, Mostafavi et al 2017
Identifying genetic variants that affect viability in large cohorts
“Morphometricity As a Measure of the Neuroanatomical Signature of a Trait”, Sabuncu et al 2016
Morphometricity as a measure of the neuroanatomical signature of a trait
“Genome-Wide Association Study of Cognitive Functions and Educational Attainment in UK Biobank (n = 112 151)”, Davies et al 2016
“Shared Genetic Aetiology between Cognitive Functions and Physical and Mental Health in UK Biobank (n = 112,151) and 24 GWAS Consortia”, Hagenaars et al 2016
“Genetic Contributions to Variation in General Cognitive Function: a Meta-Analysis of Genome-Wide Association Studies in the CHARGE Consortium (N = 53,949)”, Davies et al 2015
“Common Polygenic Variation Enhances Risk Prediction for Alzheimer’s Disease”, Escott-Price et al 2015
Common polygenic variation enhances risk prediction for Alzheimer’s disease
“Standard and Trace-Dose Lithium: A Systematic Review of Dementia Prevention and Other Behavioral Benefits”, Mauer et al 2014
“Evaluation of Excess Statistical-Significance Bias in Animal Studies of Neurological Diseases”, Tsilidis et al 2013
Evaluation of Excess Statistical-Significance Bias in Animal Studies of Neurological Diseases
“Terminal Dedifferentiation of Cognitive Abilities”, Wilson et al 2012
“Drugs Developed to Treat Diabetes, Liraglutide and Lixisenatide, Cross the Blood Brain Barrier and Enhance Neurogenesis”, Hunter & Hölscher 2012
“Most Reported Genetic Associations With General Intelligence Are Probably False Positives”, Chabris et al 2012
Most reported genetic associations with general intelligence are probably false positives
“How Citation Distortions Create Unfounded Authority: Analysis of a Citation Network”, Greenberg 2009
How citation distortions create unfounded authority: analysis of a citation network
“Lithium Trial in Alzheimer’s Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study”
View PDF:
“Lithium May Be Useful in the Prevention of Alzheimer’s Disease in Individuals at Risk of Presenile Familial Alzheimer’s Disease”, Yeh & Tsai 2008
View PDF:
“Temporal Cortex Direct Current Stimulation Enhances Performance on a Visual Recognition Memory Task in Alzheimer Disease”
“A Feasibility and Tolerability Study of Lithium in Alzheimer’s Disease”
A feasibility and tolerability study of lithium in Alzheimer’s disease :
“Prevalence of Cognitive Impairment without Dementia in the United States”, Plassman et al 2008
Prevalence of cognitive impairment without dementia in the United States
“Smoking As a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies”, Anstey et al 2007
Smoking as a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies
“Lithium and Risk for Alzheimer’s Disease in Elderly Patients With Bipolar Disorder”, Nunes 2007
Lithium and risk for Alzheimer’s disease in elderly patients with bipolar disorder :
“Global Prevalence of Dementia: a Delphi Consensus Study”, Ferri et al 2005
“Bayesian Value-Of-Information Analysis: an Application to a Policy Model of Alzheimer’s Disease”, Caxton 2001
Bayesian value-of-information analysis: an application to a policy model of Alzheimer’s disease :
“Worldwide Prevalence and Incidence of Dementia”, Fratiglioni et al 1999
“Aging, Alzheimer’s Disease and Protein Crosslinking”, Klonowska & Klonowski 1986
“Aging, Crosslinking and Alzheimer’s Disease”, Bjorksten et al 1984
“Aluminum As a Cause of Senile Dementia”, Bjorksten 1982b
“Dietary Aluminum and Alzheimer’s Disease”, Bjorksten 1982
“Associations of Semaglutide With First-Time Diagnosis of Alzheimer’s Disease in Patients With Type 2 Diabetes: Target Trial Emulation Using Nationwide Real-World Data in the US”
“The Alzheimer Photo”
“Lithium’s Potential Role in Preventing Alzheimer’s Disease”
Lithium’s Potential Role in Preventing Alzheimer’s Disease :
“Digital Biomarkers for Alzheimer’s Disease: the Mobile/wearable Devices Opportunity”
Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity
“The Woman Who Could Smell Parkinson’s”
“The Academic Culture of Fraud”
The Academic Culture of Fraud :
View External Link:
https://www.palladiummag.com/2024/08/02/the-academic-culture-of-fraud/
“12-Month Neurological and Psychiatric Outcomes of Semaglutide Use for Type 2 Diabetes: a Propensity-Score Matched Cohort Study”
“Why Do Humans Still Have a Gene That Increases the Risk of Alzheimer’s?”
Why Do Humans Still Have a Gene That Increases the Risk of Alzheimer’s?
Wikipedia
Miscellaneous
-
/doc/psychiatry/alzheimers/2023-eyting-figure1a-discontinuityinvaccineuse.jpg: -
https://www.axios.com/2024/06/29/two-bidens-trump-debate-2024-president -
https://www.newyorker.com/news/annals-of-inquiry/how-to-find-a-missing-person-with-dementia -
https://www.nytimes.com/2017/07/14/opinion/sunday/alzheimers-cure-south-america.html -
https://www.nytimes.com/2023/05/20/health/elderly-move-managers.html -
https://www.quantamagazine.org/what-causes-alzheimers-scientists-are-rethinking-the-answer-20221208/ -
https://www.science.org/content/blog-post/faked-beta-amyloid-data-what-does-it-mean -
https://www.science.org/content/blog-post/stroke-trial-concerns -
https://www.wired.com/story/parents-dementia-robots-warm-technology/:View External Link:
https://www.wired.com/story/parents-dementia-robots-warm-technology/
Bibliography
-
2025-fang.pdf: “Lifetime Risk and Projected Burden of Dementia”, -
2023-gonzales.pdf: “Senolytic Therapy in Mild Alzheimer’s Disease: a Phase 1 Feasibility Trial”, -
https://www.nytimes.com/2023/07/20/magazine/family-genetics-frontotemporal-dementia.html: “The Vanishing Family: They All Have a 50-50 Chance of Inheriting a Cruel Genetic Mutation—Which Means Disappearing into Dementia in Middle Age. This Is the Story of What It’s like to Live With Those Odds”, -
https://www.medrxiv.org/content/10.1101/2023.05.23.23290253.full: “Causal Evidence That Herpes Zoster Vaccination Prevents a Proportion of Dementia Cases”, -
https://www.nature.com/articles/s41588-022-01024-z: “New Insights into the Genetic Etiology of Alzheimer’s Disease and Related Dementias”, -
https://www.nature.com/articles/s41380-021-01138-6: “The Viral Hypothesis: How Herpesviruses May Contribute to Alzheimer’s Disease”,